Aspen EME partners with EMAS to advance education on menopause-related care

GSM is a highly prevalent condition that can significantly affect the quality of life of postmenopausal women, yet it remains underdiagnosed and undertreated in many clinical settings. The webinar series brought together leading experts in women’s health from across Europe to unpack key aspects of the condition, including its underlying pathophysiology, symptom burden and the barriers that contribute to delayed diagnosis and treatment.

Across the sessions, discussions emphasised the importance of early recognition, open and effective patient–physician communication, and practical approaches to diagnosis and management in everyday clinical practice. By combining evidence-based clinical knowledge with real-world insights, the webinars equipped healthcare professionals with tools to better identify and support patients affected by GSM.

The collaboration with EMAS reflects Aspen’s continued commitment to supporting medical education, scientific exchange and improved outcomes in women’s health. Through initiatives such as this, Aspen aims to help bridge knowledge gaps, strengthen clinical confidence and contribute to ongoing improvements in the standard of care for women experiencing GSM.

Click here to watch the latest webinar.